MCO
56
3
CNX
48
4
FOX
26
-2
PH
60
-2
CNP
70
2
GM
57
-6
ORLY
58
8
AZO
48
-2
QRVO
59
6
MAT
30
-2
INTC
61
5
UNP
50
2
ETN
55
-2
PNC
59
3
PNR
30
-2
HPE
63
4
EOG
62
6
MS
61
2
LB
55
7
PYPL
32
3
MCO
56
3
CNX
48
4
FOX
26
-2
PH
60
-2
CNP
70
2
GM
57
-6
ORLY
58
8
AZO
48
-2
QRVO
59
6
MAT
30
-2
INTC
61
5
UNP
50
2
ETN
55
-2
PNC
59
3
PNR
30
-2
HPE
63
4
EOG
62
6
MS
61
2
LB
55
7
PYPL
32
3
Financhill
Back

Armata Pharmaceuticals, Inc. 10K Form

Buy
54

ARMP
Armata Pharmaceuticals, Inc.

Last Price:
$10.64
Seasonality Move:
2.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $4.9M
Cash Flow: $-6.7M
Price / Cash Flow: 0
Annual Sales: $-6.00
Price / Book: 0

Profitability

EPS (TTM): -4.78700
Net Income (TTM): $-173.8M
Gross Margin: $3.4M
Return on Equity: 0%
Return on Assets: -196.13%

Armata Pharmaceuticals, Inc. Earnings Forecast

Key Armata Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 32 years for ARMP is 68.78%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 253.04% of Gross Profit Margin.
  • The Research & Development expenses have been 483.63% of Revenue.
  • The Net Earning history of ARMP is -3,544.03% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 15 years.

Armata Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: -1.32
Current Ratio: 1.19
Quick Ratio: 0.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Buy
54
Armata Pharmaceuticals, Inc. (ARMP) is a Buy

Is Armata Pharmaceuticals, Inc. a Buy or a Sell?